Paola Nisticò

IRCCS Regina Elena National Cancer Institute

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (20)

Collaborators (7)

raul pellini

Istituto Regina Elena

Daniel D'Andrea

University of Nottingham

UNITED KINGDOM

Stefano Ugel

Associate Professor

University of Verona

Beatrice Belmonte

Associate Professor of Pathology

University of Palermo

Roberta Sommaggio

University of Padua

Michele Maio

antonio sica

Università degli Studi del Piemonte Orientale Amedeo Avogadro

Paola Nisticò

Research Interests

Explore related searches

Contact this professor

Articles (20)

Collaborators (7)

raul pellini

Daniel D'Andrea

Stefano Ugel

Beatrice Belmonte

Roberta Sommaggio

Michele Maio

antonio sica

How do I reach out?

Meet Kite AI

Paola Nisticò

Research Interests

Explore related searches

Contact this professor

Articles (20)

Highlighting recent achievements to advance more effective cancer immunotherapy.

Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer

ADA/CD26 axis increases intra-tumor PD-1 + CD28 + CD8 + T-cell fitness and affects NSCLC prognosis and response to ICB

AI drives the assessment of lung cancer microenvironment composition.

Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLC.

Integrating AI-powered digital pathology and imaging mass cytometry identifies key classifiers of tumor cells, stroma, and immune cells in non-small cell lung cancer.

Cancer immunity and immunotherapy beyond COVID-19.

Stereotactic Ablative Radiation Therapy in 3 Fractions Induces a Favorable Systemic Immune Cell Profiling in Prostate Cancer Patients.

CD28/PD1 co-expression: dual impact on CD8+ T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response

Transcription factors in fibroblast plasticity and CAF heterogeneity.

Machine learning endometrial cancer risk prediction model: integrating guidelines of European Society for Medical Oncology with the tumor immune framework.

Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials.

T-cell repertoire diversity: friend or foe for protective antitumor response?

Microenvironmental Factors in Oral Cavity Squamous Cell Carcinoma Undergoing Surgery: Correlation with Diffusion Kurtosis Imaging and Dynamic Contrast-Enhanced MRI.

A Systematic Review on the Impact of Hypofractionated and Stereotactic Radiotherapy on Immune Cell Subpopulations in Cancer Patients.

Strategies for Efficient Targeting of Tumor Collagen for Cancer Therapy.

Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15-16, 2020.

Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11-13 2019, Verona, Italy.

Actin Cytoskeleton Dynamics and Type I IFN-Mediated Immune Response: A Dangerous Liaison in Cancer?

A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation.

Collaborators (7)

raul pellini

Daniel D'Andrea

Stefano Ugel

Beatrice Belmonte

Roberta Sommaggio

Michele Maio

antonio sica

How do I reach out?

Meet Kite AI